Apr 15, 2020
The global rare neurological disease treatment market is expected to reach US$13,830.96 million by 2027 from US$ 7,300.12 million in 2019
Mar 25, 2020
Wynford Dore, Presenting New Neuroscientific Research in First-Ever Autism Conference Appearance, to Share Stage with Dr. Albert Mensah
Dec 05, 2019
Biohaven Announces Issuance of Composition of Matter Patent on Troriluzole by the U.S. Patent and Trademark Office
Nov 05, 2019
CODA Biotherapeutics Announces Series A Extension, Bringing Total Round to $34 Million
Oct 08, 2019
Expesicor Receives Fast-Track SBIR Grant From The National Institutes Of Health
Aug 28, 2019
Neurorehabilitation Devices Market to be Worth US$3.2 Billion by 2024, Rising Prevalence of Neurological Disorders to Accelerate Demand Globally - TMR
May 14, 2019
Brain imaging AI leader icometrix raises $18 million in new funding
Apr 24, 2019
Young Blood Plasma Parkinson's Disease Investigation Three-Month Results Show Dramatic Improvements in Every Neurological Assessment Category
Jan 29, 2019
Healthpointe Welcomes Newest Neurological and Pain Management Expert
Aug 08, 2018
New Guideline Released for Managing Vegetative and Minimally Conscious States
Jul 10, 2018
Just a Few Tickets Remain For Roskamp Institute's Grey Matters Symposium on Alzheimer's Disease Research
May 22, 2018
NanoSomiX, Inc. Announces Issuance of First US Patent
Oct 18, 2017
Deep Brain Stimulators Market to Grow at 17.2% CAGR From 2012 to 2020: Million Insights
Sep 27, 2017
Evogen Receives U.S. Patent Covering Its Novel Epilepsy Blood Test